1172132

AltaThera Pharmaceuticals LLC — FEI 3013989010

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 17, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Chicago, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673021 CFR 314.80(b)Failure to develop written procedures
683221 CFR 314.80(c)(2)Late submission of annual safety reports
684221 CFR 314.80(j)Failure to maintain records
891221 CFR 314.81(b)(2)Timely submission